Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deucrictibant for Prophylaxis and On-demand Treatment of Acquired Angioedema (CREAATE)
NCT07266805Phase 3Recruiting
- Sponsor
- Pharvaris
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of deucrictibant in acquired angioedema due to C1 inhibitor deficiency (C1INH-AAE), sponsored by Pharvaris. Started Oct 2025; status: recruiting.
02
Drugs
deucrictibant
03
Conditions
acquired angioedema due to C1 inhibitor deficiency (C1INH-AAE)
Beyond the preview
Go deeper on NCT07266805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07266805.